Pages that link to "Q34301803"
Jump to navigation
Jump to search
The following pages link to Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations (Q34301803):
Displaying 50 items.
- Hybrid approach for predicting coreceptor used by HIV-1 from its V3 loop amino acid sequence (Q21559666) (← links)
- Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch (Q24672335) (← links)
- Current perspectives on HIV-1 antiretroviral drug resistance (Q26852626) (← links)
- Clinical significance of HIV-1 coreceptor usage (Q27691426) (← links)
- HIV-1 envelope subregion length variation during disease progression (Q30397933) (← links)
- Antigenic and 3D structural characterization of soluble X4 and hybrid X4-R5 HIV-1 Env trimers (Q30580101) (← links)
- Phylodynamics of HIV-1 in lymphoid and non-lymphoid tissues reveals a central role for the thymus in emergence of CXCR4-using quasispecies (Q30834495) (← links)
- HIV-1 tropism dynamics and phylogenetic analysis from longitudinal ultra-deep sequencing data of CCR5- and CXCR4-using variants (Q30836893) (← links)
- An evolutionary-network model reveals stratified interactions in the V3 loop of the HIV-1 envelope. (Q33307183) (← links)
- Chemokine coreceptor signaling in HIV-1 infection and pathogenesis (Q33521304) (← links)
- Different tempo and anatomic location of dual-tropic and X4 virus emergence in a model of R5 simian-human immunodeficiency virus infection (Q33558676) (← links)
- Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies (Q33719511) (← links)
- HIV-1 Transmission, Replication Fitness and Disease Progression (Q33758570) (← links)
- Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa (Q33793066) (← links)
- Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region (Q33853183) (← links)
- Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry (Q33857491) (← links)
- Tropism testing in the clinical management of HIV-1 infection (Q33869686) (← links)
- "Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance (Q33877312) (← links)
- Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing (Q33951977) (← links)
- Resistance to the CCR5 Inhibitor 5P12-RANTES Requires a Difficult Evolution from CCR5 to CXCR4 Coreceptor Use (Q33961704) (← links)
- Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist (Q34055508) (← links)
- Stochastic model of in-vivo X4 emergence during HIV infection: implications for the CCR5 inhibitor maraviroc (Q34367158) (← links)
- Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C. (Q34425169) (← links)
- N-Glycans in the gp120 V1/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralization (Q34503510) (← links)
- The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing (Q34558508) (← links)
- Increased functional stability and homogeneity of viral envelope spikes through directed evolution (Q34611144) (← links)
- HIV entry inhibitors. (Q34654433) (← links)
- HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected]. (Q34716813) (← links)
- Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial (Q35043417) (← links)
- Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120v₃ signatures in the regulation of co-receptor usage (Q35052934) (← links)
- Persistence and emergence of X4 virus in HIV infection (Q35055322) (← links)
- Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies (Q35102328) (← links)
- Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms (Q35330357) (← links)
- Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection (Q35635163) (← links)
- Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism (Q35635933) (← links)
- A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops (Q35666270) (← links)
- Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies (Q35784605) (← links)
- Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutations (Q35785164) (← links)
- Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate (Q35785244) (← links)
- Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage (Q35859926) (← links)
- Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. (Q35947561) (← links)
- Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching (Q35947621) (← links)
- Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote. (Q35985849) (← links)
- Evolution of coreceptor utilization to escape CCR5 antagonist therapy. (Q36003168) (← links)
- Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures (Q36086642) (← links)
- Primary isolates of human immunodeficiency virus type 1 are usually dominated by the major variants found in blood (Q36099064) (← links)
- Mutational pathways and genetic barriers to CXCR4-mediated entry by human immunodeficiency virus type 1. (Q36191170) (← links)
- Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates (Q36382002) (← links)
- Subtype-specific conformational differences within the V3 region of subtype B and subtype C human immunodeficiency virus type 1 Env proteins (Q36424523) (← links)
- Effects of partial deletions within the human immunodeficiency virus type 1 V3 loop on coreceptor tropism and sensitivity to entry inhibitors (Q36424584) (← links)